A citation-based method for searching scientific literature

Yoshimasa Aso, Maiko Fukushima, Masaaki Sagara, Teruo Jojima, Toshie Iijima, Kunihiro Suzuki, Atsushi Momobayashi, Kikuo Kasai, Toshihiko Inukai. Diabetes Res Clin Pract 2015
Times Cited: 23







List of co-cited articles
76 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Sitagliptin inhibit human lymphocytes proliferation and Th1/Th17 differentiation in vitro.
Marcelo Maia Pinheiro, Caroline Lais Stoppa, Claudete Justina Valduga, Cristina Eunice Okuyama, Renata Gorjão, Regina Mara Silva Pereira, Susana Nogueira Diniz. Eur J Pharm Sci 2017
40
34

The effect of dipeptidyl peptidase-IV inhibition on circulating T cell subpopulations in patients with type 2 diabetes mellitus.
Lucie Sromova, Petr Busek, Helena Posova, Jana Potockova, Pavel Skrha, Michal Andel, Aleksi Sedo. Diabetes Res Clin Pract 2016
17
29

Sitagliptin exerts an antinflammatory action.
Antoine Makdissi, Husam Ghanim, Mehul Vora, Kelly Green, Sanaa Abuaysheh, Ajay Chaudhuri, Sandeep Dhindsa, Paresh Dandona. J Clin Endocrinol Metab 2012
174
21

Elevated proinflammatory cytokine production by a skewed T cell compartment requires monocytes and promotes inflammation in type 2 diabetes.
Madhumita Jagannathan-Bogdan, Marie E McDonnell, Hyunjin Shin, Qasim Rehman, Hatice Hasturk, Caroline M Apovian, Barbara S Nikolajczyk. J Immunol 2011
258
21

The new insights from DPP-4 inhibitors: their potential immune modulatory function in autoimmune diabetes.
Yunjuan Zhao, Lin Yang, Xiangbing Wang, Zhiguang Zhou. Diabetes Metab Res Rev 2014
39
17

A dipeptidyl peptidase-4 inhibitor, sitagliptin, exerts anti-inflammatory effects in type 2 diabetic patients.
Noriko Satoh-Asahara, Yousuke Sasaki, Hiromichi Wada, Mayu Tochiya, Azusa Iguchi, Reiko Nakagawachi, Shinji Odori, Shigeo Kono, Koji Hasegawa, Akira Shimatsu. Metabolism 2013
127
17

The alteration of Th1/Th2/Th17/Treg paradigm in patients with type 2 diabetes mellitus: Relationship with diabetic nephropathy.
Cuiping Zhang, Chunchun Xiao, Peng Wang, Wenhua Xu, Aimei Zhang, Qing Li, Xiucai Xu. Hum Immunol 2014
71
17


Dipeptidyl peptidase inhibitors, an emerging drug class for inflammatory disease?
Roger Yazbeck, Gordon S Howarth, Catherine A Abbott. Trends Pharmacol Sci 2009
182
13


Combined treatment with sitagliptin and vitamin D in a patient with latent autoimmune diabetes in adults.
E Rapti, S Karras, M Grammatiki, A Mousiolis, X Tsekmekidou, E Potolidis, P Zebekakis, M Daniilidis, K Kotsa. Endocrinol Diabetes Metab Case Rep 2016
21
14

Reversal of new-onset diabetes through modulating inflammation and stimulating beta-cell replication in nonobese diabetic mice by a dipeptidyl peptidase IV inhibitor.
Lei Tian, Jie Gao, Jianqiang Hao, Yu Zhang, Huimin Yi, Timothy D O'Brien, Robert Sorenson, Jian Luo, Zhiguang Guo. Endocrinology 2010
87
13

Bullous pemphigoid and dipeptidyl peptidase IV inhibitors: a case-noncase study in the French Pharmacovigilance Database.
J Béné, G Moulis, I Bennani, M Auffret, P Coupe, S Babai, D Hillaire-Buys, J Micallef, S Gautier. Br J Dermatol 2016
91
13

Dipeptidyl peptidase-4 inhibitors in type 2 diabetes may reduce the risk of autoimmune diseases: a population-based cohort study.
Seoyoung C Kim, Sebastian Schneeweiss, Robert J Glynn, Michael Doherty, Allison B Goldfine, Daniel H Solomon. Ann Rheum Dis 2015
57
13

Cut to the chase: a review of CD26/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system.
C Klemann, L Wagner, M Stephan, S von Hörsten. Clin Exp Immunol 2016
177
13


DPP4 in Diabetes.
Diana Röhrborn, Nina Wronkowitz, Juergen Eckel. Front Immunol 2015
178
13

Dipeptidyl peptidase IV inhibitor sitagliptin reduces local inflammation in adipose tissue and in pancreatic islets of obese mice.
A D Dobrian, Q Ma, J W Lindsay, K A Leone, K Ma, J Coben, E V Galkina, J L Nadler. Am J Physiol Endocrinol Metab 2011
108
13

Serum level of soluble CD26/dipeptidyl peptidase-4 (DPP-4) predicts the response to sitagliptin, a DPP-4 inhibitor, in patients with type 2 diabetes controlled inadequately by metformin and/or sulfonylurea.
Yoshimasa Aso, Noriyuki Ozeki, Tomoko Terasawa, Rika Naruse, Kenji Hara, Mariko Suetsugu, Kohzo Takebayashi, Mitsuei Shibazaki, Kohsuke Haruki, Kimio Morita,[...]. Transl Res 2012
56
13

Expression of IL-37 contributes to the immunosuppressive property of human CD4+CD25+ regulatory T cells.
Xu Shuai, Li Wei-min, Ya-lin Tong, Ning Dong, Zhi-yong Sheng, Yong-ming Yao. Sci Rep 2015
31
13

Changes of Regulatory T Cells and of Proinflammatory and Immunosuppressive Cytokines in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis.
Yong-Chao Qiao, Jian Shen, Lan He, Xue-Zhi Hong, Fang Tian, Yan-Hong Pan, Ling Liang, Xiao-Xi Zhang, Hai-Lu Zhao. J Diabetes Res 2016
46
13

Vitamin D3 inhibits the proliferation of T helper cells, downregulate CD4+ T cell cytokines and upregulate inhibitory markers.
Vida Sheikh, Pinar Kasapoglu, Alireza Zamani, Zahra Basiri, Ahmad Tahamoli-Roudsari, Mahdi Alahgholi-Hajibehzad. Hum Immunol 2018
21
14

Regulatory function of CD4+CD25++ T cells in patients with myasthenia gravis is associated with phenotypic changes and STAT5 signaling: 1,25-Dihydroxyvitamin D3 modulates the suppressor activity.
Mahdi Alahgholi-Hajibehzad, Piraye Oflazer, Fikret Aysal, Hacer Durmuş, Yeşim Gülşen-Parman, Alexander Marx, Feza Deymeer, Güher Saruhan-Direskeneli. J Neuroimmunol 2015
28
13

The effect of interleukin (IL)-21 and CD4+ CD25++ T cells on cytokine production of CD4+ responder T cells in patients with myasthenia gravis.
M Alahgholi-Hajibehzad, H Durmuş, F Aysal, Y Gülşen-Parman, P Oflazer, F Deymeer, G Saruhan-Direskeneli. Clin Exp Immunol 2017
8
37

Decreased regulatory function of CD4+CD25+CD45RA+ T cells and impaired IL-2 signalling pathway in patients with type 2 diabetes mellitus.
Vida Sheikh, Alireza Zamani, Elham Mahabadi-Ashtiyani, Hanieh Tarokhian, Shiva Borzouei, Mahdi Alahgholi-Hajibehzad. Scand J Immunol 2018
14
21

IL-37 protects against obesity-induced inflammation and insulin resistance.
Dov B Ballak, Janna A van Diepen, Alexander R Moschen, Henry J Jansen, Anneke Hijmans, Gert-Jan Groenhof, Floris Leenders, Philip Bufler, Mark V Boekschoten, Michael Müller,[...]. Nat Commun 2014
128
13

1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3.
Louisa E Jeffery, Fiona Burke, Manuela Mura, Yong Zheng, Omar S Qureshi, Martin Hewison, Lucy S K Walker, David A Lammas, Karim Raza, David M Sansom. J Immunol 2009
456
13

The role of T regulatory cells in immunopathogenesis of myasthenia gravis: implications for therapeutics.
Mahdi Alahgholi-Hajibehzad, Pinar Kasapoglu, Reza Jafari, Nima Rezaei. Expert Rev Clin Immunol 2015
22
13

The imbalance of Th17/Th1/Tregs in patients with type 2 diabetes: relationship with metabolic factors and complications.
Chun Zeng, Xiaoyun Shi, Baojun Zhang, He Liu, Lianjun Zhang, Wenjun Ding, Yong Zhao. J Mol Med (Berl) 2012
145
13


Dipeptidyl peptidase IV inhibitor treatment stimulates beta-cell survival and islet neogenesis in streptozotocin-induced diabetic rats.
J Andrew Pospisilik, Jennifer Martin, Timothy Doty, Jan A Ehses, Nathalie Pamir, Francis C Lynn, Shalea Piteau, Hans-Ulrich Demuth, Christopher H S McIntosh, Raymond A Pederson. Diabetes 2003
273
8

Targeting dipeptidyl peptidase IV (CD26) suppresses autoimmune encephalomyelitis and up-regulates TGF-beta 1 secretion in vivo.
A Steinbrecher, D Reinhold, L Quigley, A Gado, N Tresser, L Izikson, I Born, J Faust, K Neubert, R Martin,[...]. J Immunol 2001
124
8

The role of gut hormones in glucose homeostasis.
Daniel J Drucker. J Clin Invest 2007
403
8

Dipeptidyl peptidase IV (DPP4) deficiency increases Th1-driven allergic contact dermatitis.
T Tasic, W Bäumer, A Schmiedl, F Schwichtenhövel, R Pabst, U Raap, S von Hörsten, M Stephan. Clin Exp Allergy 2011
17
11

Dipeptidyl peptidase 4 inhibitor sitagliptin maintains β-cell function in patients with recent-onset latent autoimmune diabetes in adults: one year prospective study.
Yunjuan Zhao, Lin Yang, Yufei Xiang, Lingjiao Liu, Gan Huang, Zhaofeng Long, Xia Li, R David Leslie, Xiangbing Wang, Zhiguang Zhou. J Clin Endocrinol Metab 2014
74
8

Effect of sitagliptin on glucose control in adult patients with Type 1 diabetes: a pilot, double-blind, randomized, crossover trial.
S L Ellis, E G Moser, J K Snell-Bergeon, A S Rodionova, R M Hazenfield, S K Garg. Diabet Med 2011
89
8

One year remission of type 1 diabetes mellitus in a patient treated with sitagliptin.
Marcos M Lima-Martínez, Ernesto Guerra-Alcalá, Miguel Contreras, José Nastasi, Janelle A Noble, Constantin Polychronakos. Endocrinol Diabetes Metab Case Rep 2014
14
14

C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus.
Carlos E B Couri, Maria C B Oliveira, Ana B P L Stracieri, Daniela A Moraes, Fabiano Pieroni, George M N Barros, Maria Isabel A Madeira, Kelen C R Malmegrim, Maria C Foss-Freitas, Belinda P Simões,[...]. JAMA 2009
268
8

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus.
Benjamin M Scirica, Deepak L Bhatt, Eugene Braunwald, P Gabriel Steg, Jaime Davidson, Boaz Hirshberg, Peter Ohman, Robert Frederich, Stephen D Wiviott, Elaine B Hoffman,[...]. N Engl J Med 2013
8


Effects of sitagliptin therapy on markers of low-grade inflammation and cell adhesion molecules in patients with type 2 diabetes.
André J Tremblay, Benoît Lamarche, Carolyn F Deacon, S John Weisnagel, Patrick Couture. Metabolism 2014
83
8

DPP-4 Inhibitors as Therapeutic Modulators of Immune Cell Function and Associated Cardiovascular and Renal Insulin Resistance in Obesity and Diabetes.
Annayya Aroor, Susan McKarns, Ravi Nistala, Vincent DeMarco, Michael Gardner, Mariana Garcia-Touza, Adam Whaley-Connell, James R Sowers. Cardiorenal Med 2013
37
8

Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy.
Rosa Barreira da Silva, Melissa E Laird, Nader Yatim, Laurence Fiette, Molly A Ingersoll, Matthew L Albert. Nat Immunol 2015
154
8

Metformin and Inflammation: Its Potential Beyond Glucose-lowering Effect.
Yoshifumi Saisho. Endocr Metab Immune Disord Drug Targets 2015
205
8

The biology of incretin hormones.
Daniel J Drucker. Cell Metab 2006
8

T-cell activation via CD26 and caveolin-1 in rheumatoid synovium.
Kei Ohnuma, Hiroshi Inoue, Masahiko Uchiyama, Tadanori Yamochi, Osamu Hosono, Nam H Dang, Chikao Morimoto. Mod Rheumatol 2006
32
8



CD26-mediated co-stimulation in human CD8(+) T cells provokes effector function via pro-inflammatory cytokine production.
Ryo Hatano, Kei Ohnuma, Junpei Yamamoto, Nam H Dang, Chikao Morimoto. Immunology 2013
49
8

A novel dipeptidyl peptidase IV inhibitor DA-1229 ameliorates streptozotocin-induced diabetes by increasing β-cell replication and neogenesis.
Jae Min Cho, Hye Won Jang, Hwanju Cheon, Yeon Taek Jeong, Do-Hoon Kim, Yu-Mi Lim, Song-Hyen Choi, Eun-Kyoung Yang, Chang-Yell Shin, Moon Ho Son,[...]. Diabetes Res Clin Pract 2011
40
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.